New Insights into the Biology of Exercise
joint with Charting a New Course for Heart Failure: From Discovery to Data
Organizer(s): Sue Bodine, Bret H. Goodpaster and John P. ThyfaultDate: March 01 - 05, 2020
Location: Keystone Resort, Keystone, CO, USA
For important information on the coronavirus, please click here
Exercise and regular physical activity are widely recognized to be important for maintaining overall health and wellness. Furthermore, exercise has been proven to be an effective therapy for the prevention and treatment of a variety of diseases including diabetes, obesity, cardiovascular disease, and cancer. The physiological response of selected tissues, such as skeletal muscle, heart, liver, adipose, and brain to exercise has been studied to varying degrees in healthy and unhealthy individuals; however, the cellular and molecular mechanisms underlying the acute responses and training adaptations to exercise remain poorly defined. The study of exercise is not a new field but is receiving increased interest because of the many health-promoting benefits of regular aerobic and resistance exercise. This conference includes selected speakers who can present new findings related to the response of multiple organs/tissues (skeletal muscle, liver, adipose tissue, heart, vascular, brain) to exercise in both animal models and humans. The overarching goals for the conference are to 1) encourage discussion of the integrative multiple organ response to exercise, 2) encourage discussion and integration of basic and translational research, and 3) provide an environment for investigators to network and initiate new collaborations.
Scholarship Deadline: October 31 2019
Discounted Abstract Deadline: October 31 2019
Abstract Deadline: December 3 2019
Discounted Registration Deadline: January 7 2020
Abstract submission is now closed. Registered attendees may bring a poster onsite. Please contact our office at +1 800-253-0685; +1 970-262-1230 or email email@example.com if you are interested.
We gratefully acknowledge additional support for this conference from:
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:
Astellas Pharma Inc.
Merck & Co., Inc.
We gratefully acknowledge the generous grant for this conference provided by:National Institute on Aging (NIA)
Grant No. 1R13AG066282-01
Funding for this conference was made possible (in part) by 1R13AG066282-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.